News and events

August 15, 2018

InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced the registration of legal entity in UK. InSysBio UK (INSYSBIO UK LIMITED) is located in Edinburgh.

InSysBio to present at AAIC 2018

July 17, 2018

InSysBio announces their participation at Alzheimer’s Association International Conference (AAIC) 2018 being held July 22-26 in Chicago, IL. InSysBio welcomes visitors at the booth #630.

InSysBio Announces Collaboration on Quantitative System Pharmacology Modeling of Chronic Obstructive Pulmonary Disease

June 13, 2018

InSysBio LLC (www.insysbio.com), a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, announced today a collaboration with GSK, one of the world's leading research-based pharmaceutical and healthcare companies, for development of QSP platform of Chronic Obstructive Pulmonary Disease (COPD).

InSysBio to present at PAGE 2018

May 24, 2018

InSysBio announces their participation at PAGE 2018 27th Meeting being held from 29 May to 1 June 2018 in Montreux, Switzerland.

InSysBio, LLC Announces Extension of Collaboration with GSK on Quantitative Systems Pharmacology Modeling in Asthma

April 26, 2018

InSysBio LLC (www.insysbio.com) – pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development – announced today further collaboration with GSK - one of the world's leading research-based pharmaceutical and healthcare companies - to expand the previously developed QSP model of asthma.

XXV Russian National Congress “Man and Drug”

April 5, 2018

InSysBio today announced their participation at XXV Russian National Congress “Man and Drug”, to be held in Moscow, Russia, on April 9-12, 2018.

InSysBio to present at the ASCPT 2018 Annual Meeting

March 15, 2018

InSysBio today announced their participation at the ASCPT 2018 Annual Meeting, to be held in Orlando, FL, on March 21-24.

InSysBio to present at AAT-AD/PD Focus Meeting 2018

March 12, 2018

InSysBio today announced their participation at AAT-AD/PD Focus Meeting 2018, to be held in Torino, Italy, on March 15-18, 2018. The Meeting is focused on all the latest breakthroughs in treatment and research in Alzheimer’s, Parkinson’s and other neurological diseases. Alexander Stepanov will present “In silico implementation of tauopathy transgenic mouse model” in the framework of session “Symposium 25: Tau in translational studies (2)”.

InSysBio modelers evaluated tau protein phosphorylation related targets for Alzheimer’s disease treatment

PUBLICATION

February 26, 2018

InSysBio continues to investigate the mechanisms underlying Alzheimer’s disease (AD) using the quantitative systems pharmacology (QSP) modeling approach. The part of QSP model describing tau protein was published in the PLOS ONE journal. This is one of more than dozen InSysBio publications in AD area during last seven years.

InSysBio Annual Internal Scientific Meeting

February 20, 2018

14-16 February 2018 InSysBio held Annual Internal Scientific Meeting.